Intestinal Cell News Volume 6.26 | July 17 2020

    0
    28







    2020-07-17 | ICN 6.26


    Intestinal Cell News by STEMCELL Technologies
    Vol. 6.26 – 17 July, 2020
    TOP STORY

    Activating Transcription Factor 6 Mediates Inflammatory Signals in Intestinal Epithelial Cells upon Endoplasmic Reticulum Stress

    Scientists studied the pathways that regulate activating transcription factor 6 and its role for inflammation in intestinal epithelial cells.
    [Gastroenterology]

    Abstract

    Watch 'collaborating to accelerate COVID-19 research'
    PUBLICATIONSRanked by the impact factor of the journal

    Cathelicidin-Mediated Lipopolysaccharide Signaling via Intracellular TLR4 in Colonic Epithelial Cells Evokes CXCL8 Production

    In addition to its known microbicidal action, cathelicidin had a unique pathogen-sensing role, facilitating LPS-mediated intestinal responses, including the production of CXCL8/CXCL1 that would contribute to an integrated tissue response to recruit neutrophils during colitis.
    [Gut Microbes]

    Full Article

    Itraconazole Inhibits the Hedgehog Signaling Pathway thereby Inducing Autophagy-Mediated Apoptosis of Colon Cancer Cells

    Researchers investigated whether itraconazole induced autophagy-mediated cell death of colon cancer cells through the Hedgehog signaling pathway.
    [Cell Death & Disease]

    Full Article

    PHLPP2 Is Regulated by Competing Endogenous RNA Network in Pathogenesis of Colon Cancer

    Investigators unraveled the possible involvement of long noncoding RNAs and microRNAs regulating pleckstrin-homology-domain leucine-rich-repeat protein phosphatases (PHLPP2 ) in colon cancer.
    [Aging]

    Full Article

    GLUT5 Regulation by AKT1/3-MiR-125b-5p Downregulation Induces Migratory Activity and Drug Resistance in TLR-Modified Colorectal Cancer Cells

    Scientists investigated the effects of AKT-mediated miR-125b-5p alteration on metabolic changes and examined how these molecules enhanced migration and induced drug resistance in colon cancer cells.
    [Carcinogenesis]

    Abstract

    Salinomycin Inhibits Epigenetic Modulator EZH2 to Enhance Death Receptors in Colon Cancer Stem Cells

    By harnessing cancer stem cell specific cytotoxic function of salinomycin, the authors discovered a critical role of epigenetic modulator EZH2 in regulating the expression of death receptors in colon cancer stem cells.
    [Epigenetics]

    Abstract

    AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

    Researchers demonstrated that inhibition of AXL signaling with the small molecule inhibitor BGB324 abrogated both matrix-stiffness and transforming growth factor beta–induced fibrogenesis in human colonic myofibroblasts.
    [Inflammatory Bowel Diseases]

    Abstract

    Piperine Suppresses the Wnt/β-Catenin Pathway and Has Anti-Cancer Effects on Colorectal Cancer Cells

    By using Wnt/β-catenin pathway epistasis experiment, scientists showed that piperine inhibited the canonical Wnt pathway induced by overexpression of β-catenin, β-catenin S33A or dnTCF4 VP16, while also suppressing β-catenin nuclear localization in a HCT116 cell line.
    [Scientific Reports]

    Full Article

    Alginate Oligosaccharides Enhance Small Intestine Cell Integrity and Migration Ability

    Investigators explored the effects of alginate oligosaccharides on the integrity and migration of small intestine cells using swine intestinal epithelial IPEC-J2 cells.
    [Life Sciences]

    Abstract

    Download an e-book covering the evolution of organoids, from their development to updated applications and future outlooks.
    REVIEWS

    Cell Death in the Gut Epithelium and Implications for Chronic Inflammation

    The authors discuss the underlying molecular and cellular underpinnings that control programmed cell death in intestinal epithelial cells, which emerge during intestinal diseases.
    [Nature Reviews Gastroenterology & Hepatology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Mylan and Fujifilm Kyowa Kirin Biologics Announce US FDA Approval of Hulio®

    Mylan N.V. and Fujifilm Kyowa Kirin Biologics Co., Ltd. announced that the FDA has approved Hulio® for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult crohn’s disease, ulcerative colitis and plaque psoriasis, in both prefilled syringe and auto-injector presentations.
    [Mylan]

    Press Release

    During the Pandemic, Students Do Field and Lab Work without Leaving Home

    Some researchers worry students will miss out on certain practical and problem-solving skills and won’t be able to judge whether the hands-on work of a scientist is a good fit for them. But instructors are developing high-tech ways to simulate the field and lab experiences.
    [Science Insider]

    Editorial

    Open-Access Plan S to Allow Publishing in Any Journal

    Funding agencies behind the radical open-access initiative Plan S have announced a policy that could make it possible for researchers to bypass journals’ restrictions on open publishing.
    [Nature News]

    Editorial

    FEATURED EVENT

    Transcription and Chromatin

    August 27 – August 29
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Colorectal Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – Molecular Diagnostics and Experimental Therapeutics

    City of Hope – Monrovia, California, United States

    Research Scientist – In Vivo Research on Wnt Signaling in Self-Renewal

    Surrozen, Inc. – South San Francisco, California, United States

    Cancer Biology Invesigator – Cancer Epigenetics

    GSK – Collegeville, Pennsylvania, United States

    Lab Manager – Intestinal Research

    Howard Hughes Medical Institute – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter